CRI(CRI)
CRI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $2.98B | $3.03B | $3.05B |
| Low | $2.94B | $2.99B | $2.95B |
| High | $3.02B | $3.06B | $3.15B |
| EBITDA Avg | $375M | $381M | $384M |
| Low | $370M | $376M | $372M |
| High | $379M | $385M | $396M |
| EBIT Avg | $310M | $315M | $318M |
| Low | $306M | $311M | $308M |
| High | $314M | $319M | $328M |
| Net Income Avg | $116M | $130M | $142M |
| Low | $115M | $123M | $130M |
| High | $116M | $135M | $153M |
| EPS Avg | $3.27 | $3.64 | $3.98 |
| Low | $3.25 | $3.48 | $3.66 |
| High | $3.28 | $3.80 | $4.31 |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 4 | 4 / 2 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $766M | $931M | $689M | $614M | $769M | $938M |
| Low | $764M | $928M | $687M | $612M | $767M | $936M |
| High | $767M | $933M | $690M | $615M | $771M | $940M |
| EBITDA Avg | $96M | $117M | $87M | $77M | $97M | $118M |
| Low | $96M | $117M | $86M | $77M | $97M | $118M |
| High | $97M | $117M | $87M | $77M | $97M | $118M |
| EBIT Avg | $80M | $97M | $72M | $64M | $80M | $98M |
| Low | $79M | $97M | $72M | $64M | $80M | $97M |
| High | $80M | $97M | $72M | $64M | $80M | $98M |
| Net Income Avg | $32M | $63M | $19M | $9M | $35M | $62M |
| Low | $32M | $62M | $19M | $9M | $35M | $62M |
| High | $32M | $63M | $19M | $9M | $35M | $62M |
| EPS Avg | $0.90 | $1.77 | $0.55 | $0.26 | $0.98 | $1.75 |
| Low | $0.89 | $1.76 | $0.55 | $0.26 | $0.98 | $1.74 |
| High | $0.90 | $1.77 | $0.55 | $0.26 | $0.98 | $1.75 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |